72049723RFI00002: RFI: USAID Local Solutions to Health Priorities in Indonesia (LSHP)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Indonesia USAID-Jakarta notices from 2023.
Indonesia USAID-Jakarta offered grants of up to $25.0 million (at least $5.0 million) to the applicants described in the notice. It expected to make about 5 awards. Applications closed on February 24, 2023.
From the official notice on Grants.gov, last changed February 6, 2023. Checked November 7, 2026.
- Award ceiling$25.0 million
- Award floor$5.0 million
- Expected awards5
- Cost sharingNot required
- Funding typeOther
Key dates
| Posted | February 6, 2023 |
|---|---|
| Deadline | February 24, 2023 |
| Archived by Grants.gov | March 26, 2023 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Local Indonesia Non-Governmental Organizations (NGOs)
Is this a realistic fit?
- Past USAID Foreign Assistance for Programs Overseas awards averaged $8.7 million; this notice allows up to $25.0 million per award.
- Most of the program's money (54% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
RFI NUMBER: 72049723RFI00002 ISSUANCE DATE: February 06, 2023 RESPONSE DUE DATE AND TIME: February 24, 2023; 15:00 Jakarta Time RESPONSE EMAIL ADDRESS: applications-indonesia@usaid.gov SUBJECT: USAID Local Solutions to Health Priorities in Indonesia (LSHP) Dear Prospective Respondents and Interested Parties, The United States Government, represented by the U.S. Agency for International Development (USAID) in Indonesia, is in the process of designing an activity to support its localization efforts. USAID is publishing this Request for Information (RFI) pursuant to FAR 52.215-3 to conduct market research, and gauge interest from qualified organizations for the draft Activity Description. This announcement is an RFI, issued solely for information and planning purposes and does not constitute a request for application. Responses to this request for information are not binding on the U.S. Government and do not obligate USAID to issue a solicitation, nor do they commit USAID to pay any cost incurred in the preparation and submission of comments and responses. Brief Activity Description: USAID is committed to shifting more leadership, ownership, decision making, and implementation to the local people and institutions who possess the capability, connectedness, and credibility to drive change in their own countries and communities. This enhanced localization approach will require a different way of doing business internally to USAID and for our partners including Indonesian organizations and government institutions. If USAID/Indonesia decides to proceed with a funding opportunity, then up to five (5) awards to local partners to implement activities in Health and Global Health Security program areas with an overall estimated up to $25 million (i.e., each award valued at approximately $5 million), over 5 years are anticipated, subject to the availability of funds. The funding opportunity for the anticipated Activities will be utilizing modality one of the NPI APS. i.e., Direct awards to new and underutilized organizations that are local entities in the host country in which an applicant is applying. It will involve a brief concept submission, followed by co-creation, before soliciting full applications from the finalists. While the Activities design is still in progress, USAID envisions that local organizations might propose partnering with other local organizations or even with international partners as part of a consortium.
Who has won USAID Foreign Assistance for Programs Overseas grants before
From fiscal 2021 to 2025, USAID Foreign Assistance for Programs Overseas (98.001) awarded $37 billion across 4,233 grant awards, an average of $8.7 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Miscellaneous Foreign Awardees | District of Columbia | 489 | $6.9 billion |
| Family Health International | North Carolina | 91 | $2.1 billion |
| Catholic Relief Services - United States Conference of Catholic Bishops | Maryland | 128 | $1.2 billion |
| Save the Children Federation, Inc. | Connecticut | 100 | $814 million |
| Research Triangle Institute | North Carolina | 33 | $756 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is 72049723RFI00002 still open?
No. It closed on February 24, 2023.
Who can apply for RFI: USAID Local Solutions to Health Priorities in Indonesia (LSHP)?
Indonesia USAID-Jakarta accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for RFI: USAID Local Solutions to Health Priorities in Indonesia (LSHP)?
Closed February 24, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $25.0 million each.
Who has won USAID Foreign Assistance for Programs Overseas grants before?
The largest recipients over five fiscal years were Miscellaneous Foreign Awardees, Family Health International, Catholic Relief Services - United States Conference of Catholic Bishops. The program made 4,233 awards worth $37 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)